PR Newswire
Conference
Call to be Held on
November 10, 2022
RANCHO CORDOVA, Calif.
,
Nov. 7, 2022
/PRNewswire/ — ThermoGenesis Holdings, Inc. (Nasdaq: THMO), a market leader in automated cell processing and point-of-care, autologous cell-based therapies, today announced that the Company will release its financial results for the third quarter ended
September 30, 2022
, and provide a corporate strategic update on
Thursday, November 10, 2022
. A conference call and webcast will follow at
1:30 p.m. PT
/
4:30 p.m. ET
.
To participate in the conference call, please dial 1-844-889-4331 (domestic), 1-412-380-7406 (international) or 1-866-605-3852 (
Canada
). To access a live webcast of the call, please visit:
.
A webcast replay will be available on ThermoGenesis’ website for three months by visiting the Investor page of the Company’s website at
www.thermogenesis.com
.
About ThermoGenesis Holdings, Inc.
ThermoGenesis Holdings, Inc. develops, commercializes, and markets a range of automated technologies for CAR-T and other cell-based therapies. The Company currently markets a full suite of solutions for automated clinical biobanking, point-of-care applications, and automation for immuno-oncology, including its semi-automated, functionally-closed CAR-TXpress™ platform, which streamlines the manufacturing process for the emerging CAR-T immunotherapy market. For more information about ThermoGenesis, please visit:
www.thermogenesis.com
.
Company Contact:
Wendy Samford
916-858-5191
[email protected]
Investor Contact:
Paula Schwartz, Rx Communications
917-322-2216
[email protected]
View original content:
https://www.prnewswire.com/news-releases/thermogenesis-holdings-to-announce-financial-results-for-the-third-quarter-ended-september-30-2022-and-provide-a-corporate-strategic-update-301670591.html
SOURCE ThermoGenesis Holdings, Inc.
Featured image: © peshkova
